What's new
By:
Filters
Cystic Fibrosis Forum (EXP)

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial

D

dasjsmum

New member
<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>saveferris2009</b></i>

<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>dasjsmum</b></i>



His lung function is about 70%...so add the benefit of this drug and it's up around 75%.</end quote></div>







Not a big deal but 5% of 70 is 3.5, not 5. So 73.5 would be expected lung function per the study (or 6% of 70 is 4.2).



<img src="i/expressions/face-icon-small-smile.gif" border="0"></end quote></div>

Oh yeah, hahaha, ofcourse <img src="i/expressions/face-icon-small-smile.gif" border="0">
 
D

dasjsmum

New member
<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>saveferris2009</b></i>

<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>dasjsmum</b></i>



His lung function is about 70%...so add the benefit of this drug and it's up around 75%.</end quote></div>







Not a big deal but 5% of 70 is 3.5, not 5. So 73.5 would be expected lung function per the study (or 6% of 70 is 4.2).



<img src="i/expressions/face-icon-small-smile.gif" border="0"></end quote></div>

Oh yeah, hahaha, ofcourse <img src="i/expressions/face-icon-small-smile.gif" border="0">
 
D

dasjsmum

New member
<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>saveferris2009</b></i>

<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>dasjsmum</b></i>



His lung function is about 70%...so add the benefit of this drug and it's up around 75%.</end quote></div>







Not a big deal but 5% of 70 is 3.5, not 5. So 73.5 would be expected lung function per the study (or 6% of 70 is 4.2).



<img src="i/expressions/face-icon-small-smile.gif" border="0"></end quote></div>

Oh yeah, hahaha, ofcourse <img src="i/expressions/face-icon-small-smile.gif" border="0">
 
D

dasjsmum

New member
<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>saveferris2009</b></i>

<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>dasjsmum</b></i>



His lung function is about 70%...so add the benefit of this drug and it's up around 75%.</end quote>







Not a big deal but 5% of 70 is 3.5, not 5. So 73.5 would be expected lung function per the study (or 6% of 70 is 4.2).



<img src="i/expressions/face-icon-small-smile.gif" border="0"></end quote>

Oh yeah, hahaha, ofcourse <img src="i/expressions/face-icon-small-smile.gif" border="0">
 
D

dasjsmum

New member
<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>saveferris2009</b></i>
<br />
<br /><div class="FTQUOTE"><begin quote><i>Originally posted by: <b>dasjsmum</b></i>
<br />
<br />
<br />
<br />His lung function is about 70%...so add the benefit of this drug and it's up around 75%.</end quote>
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />Not a big deal but 5% of 70 is 3.5, not 5. So 73.5 would be expected lung function per the study (or 6% of 70 is 4.2).
<br />
<br />
<br />
<br /><img src="i/expressions/face-icon-small-smile.gif" border="0"></end quote>
<br />
<br /> Oh yeah, hahaha, ofcourse <img src="i/expressions/face-icon-small-smile.gif" border="0">
 
C

cfsucks

Guest
<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>saveferris2009</b></i>

Why is what so?</end quote></div>

i was referencing the comment about no new drugs available in the past 10 years. i didn't know about that fact, and wondered why such a long gap.
 
C

cfsucks

Guest
<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>saveferris2009</b></i>

Why is what so?</end quote></div>

i was referencing the comment about no new drugs available in the past 10 years. i didn't know about that fact, and wondered why such a long gap.
 
C

cfsucks

Guest
<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>saveferris2009</b></i>

Why is what so?</end quote></div>

i was referencing the comment about no new drugs available in the past 10 years. i didn't know about that fact, and wondered why such a long gap.
 
C

cfsucks

Guest
<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>saveferris2009</b></i>

Why is what so?</end quote>

i was referencing the comment about no new drugs available in the past 10 years. i didn't know about that fact, and wondered why such a long gap.
 
C

cfsucks

Guest
<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>saveferris2009</b></i>
<br />
<br />Why is what so?</end quote>
<br />
<br />i was referencing the comment about no new drugs available in the past 10 years. i didn't know about that fact, and wondered why such a long gap.
 
S

saveferris2009

New member
because drug development is very hit and miss. Not every drug that makes it to Phase I makes it to Phase II, not every Phase II makes it to Phase III, and not every Phase III is approved for market (look at Azli, for example).

Plus, there is very little interest in CF drug development because there are only 70,000 of us world wide. Compare that to millions of heart disease, cancer or diabetes patients.

This is why fund raising is so important - donations incentivize drug companies and the CFF to develop CF drugs.

Check out this article: it explains why we're so fortunate to have the CFF's business model:

<a target=_blank class=ftalternatingbarlinklarge href="http://www.businessweek.com/technology/content/apr2008/tc2008042_241404.htm
">http://www.businessweek.com/te.../tc2008042_241404.htm
</a>
the CFF pipeline is pretty rich right now - but of course not all drugs will make it to market. but at least we have a much higher chance of new drugs reaching the market with this biz model.
 
S

saveferris2009

New member
because drug development is very hit and miss. Not every drug that makes it to Phase I makes it to Phase II, not every Phase II makes it to Phase III, and not every Phase III is approved for market (look at Azli, for example).

Plus, there is very little interest in CF drug development because there are only 70,000 of us world wide. Compare that to millions of heart disease, cancer or diabetes patients.

This is why fund raising is so important - donations incentivize drug companies and the CFF to develop CF drugs.

Check out this article: it explains why we're so fortunate to have the CFF's business model:

<a target=_blank class=ftalternatingbarlinklarge href="http://www.businessweek.com/technology/content/apr2008/tc2008042_241404.htm
">http://www.businessweek.com/te.../tc2008042_241404.htm
</a>
the CFF pipeline is pretty rich right now - but of course not all drugs will make it to market. but at least we have a much higher chance of new drugs reaching the market with this biz model.
 
S

saveferris2009

New member
because drug development is very hit and miss. Not every drug that makes it to Phase I makes it to Phase II, not every Phase II makes it to Phase III, and not every Phase III is approved for market (look at Azli, for example).

Plus, there is very little interest in CF drug development because there are only 70,000 of us world wide. Compare that to millions of heart disease, cancer or diabetes patients.

This is why fund raising is so important - donations incentivize drug companies and the CFF to develop CF drugs.

Check out this article: it explains why we're so fortunate to have the CFF's business model:

<a target=_blank class=ftalternatingbarlinklarge href="http://www.businessweek.com/technology/content/apr2008/tc2008042_241404.htm
">http://www.businessweek.com/te.../tc2008042_241404.htm
</a>
the CFF pipeline is pretty rich right now - but of course not all drugs will make it to market. but at least we have a much higher chance of new drugs reaching the market with this biz model.
 
S

saveferris2009

New member
because drug development is very hit and miss. Not every drug that makes it to Phase I makes it to Phase II, not every Phase II makes it to Phase III, and not every Phase III is approved for market (look at Azli, for example).

Plus, there is very little interest in CF drug development because there are only 70,000 of us world wide. Compare that to millions of heart disease, cancer or diabetes patients.

This is why fund raising is so important - donations incentivize drug companies and the CFF to develop CF drugs.

Check out this article: it explains why we're so fortunate to have the CFF's business model:

<a target=_blank class=ftalternatingbarlinklarge href="http://www.businessweek.com/technology/content/apr2008/tc2008042_241404.htm
">http://www.businessweek.com/te.../tc2008042_241404.htm
</a>
the CFF pipeline is pretty rich right now - but of course not all drugs will make it to market. but at least we have a much higher chance of new drugs reaching the market with this biz model.
 
S

saveferris2009

New member
because drug development is very hit and miss. Not every drug that makes it to Phase I makes it to Phase II, not every Phase II makes it to Phase III, and not every Phase III is approved for market (look at Azli, for example).
<br />
<br />Plus, there is very little interest in CF drug development because there are only 70,000 of us world wide. Compare that to millions of heart disease, cancer or diabetes patients.
<br />
<br />This is why fund raising is so important - donations incentivize drug companies and the CFF to develop CF drugs.
<br />
<br />Check out this article: it explains why we're so fortunate to have the CFF's business model:
<br />
<br /><a target=_blank class=ftalternatingbarlinklarge href="http://www.businessweek.com/technology/content/apr2008/tc2008042_241404.htm
">http://www.businessweek.com/te.../tc2008042_241404.htm
</a><br />
<br />the CFF pipeline is pretty rich right now - but of course not all drugs will make it to market. but at least we have a much higher chance of new drugs reaching the market with this biz model.
 
You must log in or register to reply here.
Top